Talk to your doctor before taking KEPPRA, if you

• are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of this medicine
• suffer from kidney problems
• notice any slowdown in the growth or unexpected puberty development of your child
• have had thoughts of harming or killing themselves
• have any symptoms of depression and/or suicidal ideation

• KEPPRA should not be used during pregnancy unless clearly necessary
• Breast-feeding is not recommended during treatment
• If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine

• KEPPRA is not indicated in children and adolescents below 16 years on its own (monotherapy)

• KEPPRA may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy
• You should not drive or use machines until it is established that your ability to perform such activities is not affected

• weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic (anaphylactic) reaction
• swelling of the face, lips, tongue and throat (Quinckes oedema)
• flu-like symptoms and a rash on the face followed by an extended rash with a high temperature
• low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as this may be a sign of sudden decrease of kidney function
• a skin rash which may form blisters and look like small targets (erythema multiforme)
• a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome)
• a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis)
• signs of serious mental changes or if someone around you notices signs of confusion, somnolence (sleepiness), amnesia (loss of memory), memory impairment (forgetfulness), abnormal behavior or other neurological signs including involuntary or uncontrolled movements

• nasopharyngitis
• somnolence (sleepiness), headache
• anorexia (loss of appetite)
• depression, hostility or aggression, anxiety, insomnia, nervousness or irritability
• convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling)
• vertigo (sensation of rotation)
• cough
• abdominal pain, diarrhea, dyspepsia (indigestion), vomiting, nausea
• asthenia/fatigue (tiredness)

• decreased number of blood platelets, decreased number of white blood cells
• weight decrease, weight increase
• suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation
• amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration); diplopia (double vision), vision blurred elevated/abnormal values in a liver function test
• hair loss, eczema, pruritus
• muscle weakness, myalgia (muscle pain)

• decreased number of all blood cell types
• decreased blood sodium concentration
• suicide, personality disorders (behavioral problems), thinking abnormal (slow thinking, unable to concentrate)
• uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity)
• pancreatitis
• liver failure, hepatitis
• sudden decrease in kidney function
• rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase

NA

NA

• Keep this medicine out of reach of children
• Do not use this medicine after the expiry date
• Store at room temperature (15-25C)
• Do not use after 7 months of first opening the bottle